Low-Dose Tenecteplase in Covid-19 Patients With Acute Pulmonary Embolism: A Randomized, Double-Blind, Placebo-Controlled Trial
Latest Information Update: 28 Oct 2021
At a glance
- Drugs Tenecteplase (Primary) ; Enoxaparin sodium; Heparin
- Indications COVID 2019 infections; Pulmonary embolism
- Focus Therapeutic Use
- 20 Oct 2021 Status changed from recruiting to discontinued (Identification of eligible patients was slower than anticipated).
- 08 Apr 2021 Status changed from active, no longer recruiting to recruiting.
- 23 Sep 2020 New trial record